Total Payments
$4,832
2024 Payments
$56.27
Companies
37
Transactions
315
Medicare Patients
6,502
Medicare Billing
$304,049
Payment Breakdown by Category
Food & Beverage$4,784 (99.0%)
Education$47.77 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,784 | 311 | 99.0% |
| Education | $47.77 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,219 | 87 | $0 (2022) |
| GlaxoSmithKline, LLC. | $518.27 | 40 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $430.06 | 29 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $287.24 | 17 | $0 (2019) |
| Daiichi Sankyo Inc. | $247.46 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $235.74 | 21 | $0 (2019) |
| Grifols USA, LLC | $171.06 | 12 | $0 (2019) |
| Lilly USA, LLC | $154.12 | 12 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $150.82 | 10 | $0 (2020) |
| PFIZER INC. | $149.64 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.27 | 3 | Oyster Point Pharma, Inc. ($23.56) |
| 2023 | $25.00 | 1 | Currax Pharmaceuticals LLC ($25.00) |
| 2022 | $167.57 | 10 | Biohaven Pharmaceutical Holding Company Ltd. ($39.89) |
| 2021 | $32.81 | 2 | Abbott Laboratories ($17.13) |
| 2020 | $295.36 | 13 | Novo Nordisk Inc ($193.10) |
| 2019 | $1,139 | 85 | Novo Nordisk Inc ($296.73) |
| 2018 | $1,747 | 106 | Novo Nordisk Inc ($275.35) |
| 2017 | $1,369 | 95 | Novo Nordisk Inc ($415.53) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Dry eyes | ||||||
| 05/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 10/12/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes Care | ||||||
| 09/28/2022 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $17.33 | General |
| 09/24/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: PRIMARY CARE | ||||||
| 08/26/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PRIMARY CARE | ||||||
| 08/12/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VACCINES | ||||||
| 08/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 08/03/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 07/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: PRIMARY CARE | ||||||
| 07/29/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes Care | ||||||
| 10/27/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 10/27/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 05/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 03/13/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
| 02/28/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/25/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Endocrinology | ||||||
| 01/29/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Obesity | ||||||
| 01/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,678 | 2,474 | $196,965 | $84,720 |
| 2022 | 22 | 1,155 | 1,539 | $133,621 | $53,986 |
| 2021 | 33 | 2,014 | 2,853 | $225,364 | $97,146 |
| 2020 | 28 | 1,655 | 2,197 | $177,532 | $68,197 |
Total Patients
6,502
Total Services
9,063
Medicare Billing
$304,049
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 389 | $74,299 | $32,546 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 116 | 116 | $27,840 | $14,423 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 77 | $10,010 | $4,500 | 45.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 50 | 53 | $4,399 | $3,710 | 84.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 75 | 108 | $6,912 | $3,075 | 44.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 145 | 239 | $12,667 | $3,070 | 24.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $4,420 | $2,751 | 62.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 153 | 261 | $16,704 | $2,667 | 16.0% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 19 | 19 | $4,085 | $2,656 | 65.0% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 20 | 20 | $4,300 | $2,656 | 61.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 170 | 308 | $3,080 | $2,587 | 84.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 139 | 213 | $4,899 | $1,606 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 54 | $2,160 | $1,594 | 73.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 70 | 95 | $4,465 | $1,564 | 35.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 68 | 121 | $3,751 | $1,133 | 30.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 50 | 50 | $2,000 | $864.48 | 43.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 39 | $1,677 | $561.64 | 33.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $715.00 | $383.63 | 53.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 19 | 26 | $1,118 | $374.66 | 33.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 18 | 25 | $1,075 | $334.00 | 31.1% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 19 | 26 | $728.00 | $325.00 | 44.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 28 | 35 | $1,050 | $276.85 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 29 | $2,030 | $236.04 | 11.6% |
| 83540 | Iron level | Office | 2023 | 19 | 27 | $513.00 | $171.18 | 33.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 25 | 25 | $400.00 | $141.50 | 35.4% |
About Dr. Joy Commisso, MD
Dr. Joy Commisso, MD is a Family Medicine healthcare provider based in Cicero, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326293572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joy Commisso, MD has received a total of $4,832 in payments from pharmaceutical and medical device companies, with $56.27 received in 2024. These payments were reported across 315 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,784).
As a Medicare-enrolled provider, Commisso has provided services to 6,502 Medicare beneficiaries, totaling 9,063 services with total Medicare billing of $304,049. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cicero, NY
- Active Since 12/01/2008
- Last Updated 09/19/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326293572
Products in Payments
- Ozempic (Drug) $427.61
- Victoza (Drug) $296.14
- INJECTAFER (Drug) $247.46
- Saxenda (Drug) $245.54
- TRELEGY ELLIPTA (Drug) $192.85
- ANORO (Drug) $182.55
- FARXIGA (Drug) $175.62
- XIFAXAN (Drug) $163.75
- TRULICITY (Drug) $141.27
- JANUVIA (Drug) $129.39
- Belviq (Drug) $127.02
- RYBELSUS (Drug) $125.00
- SPIRIVA RESPIMAT (Drug) $105.73
- MYRBETRIQ (Drug) $105.34
- Prolastin-C (Biological) $104.00
- SYMBICORT (Drug) $98.55
- STIOLTO (Drug) $96.51
- Trintellix (Drug) $86.32
- BREO (Drug) $84.29
- Vascepa (Drug) $79.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cicero
Daniel Rancier, Md, MD
Family Medicine — Payments: $12,897
Family Medicine $12,897
Amado Rueda, Md, MD
Family Medicine — Payments: $11,222
Family Medicine $11,222
Hernan Reyes, Md, MD
Family Medicine — Payments: $10,362
Family Medicine $10,362
Rosaura Licea, Md, MD
Family Medicine — Payments: $8,416
Family Medicine $8,416
Hemlata Meena, M.d, M.D
Family Medicine — Payments: $8,405
Family Medicine $8,405
Dennis Nave, Md, MD
Family Medicine — Payments: $6,961
Family Medicine $6,961